Aligos Therapeutics (ALGS) Other Gross PP&E Adjustments (2021 - 2025)
Aligos Therapeutics (ALGS) has disclosed Other Gross PP&E Adjustments for 5 consecutive years, with $9.8 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 28.35% year-over-year to $9.8 million, compared with a TTM value of $9.8 million through Dec 2025, up 28.35%, and an annual FY2025 reading of $9.8 million, up 28.35% over the prior year.
- Other Gross PP&E Adjustments was $9.8 million for Q4 2025 at Aligos Therapeutics, down from $10.9 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $10.9 million in Q3 2025 and bottomed at $3.4 million in Q4 2021.
- Average Other Gross PP&E Adjustments over 5 years is $7.1 million, with a median of $7.1 million recorded in 2023.
- The sharpest move saw Other Gross PP&E Adjustments fell 7.3% in 2022, then surged 60.83% in 2024.
- Year by year, Other Gross PP&E Adjustments stood at $3.4 million in 2021, then surged by 34.74% to $4.6 million in 2022, then rose by 2.38% to $4.7 million in 2023, then surged by 60.83% to $7.6 million in 2024, then increased by 28.35% to $9.8 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for ALGS at $9.8 million in Q4 2025, $10.9 million in Q3 2025, and $10.2 million in Q2 2025.